Home • Scientific literature watch • Patient Access in 14 High-Income Countries to New Antibacterials Approved by the US Food and Drug Administration, European Medicines Agency, Japanese Pharmaceuticals and Medical Devices Agency, or Health Canada, 2010–2020
[acf:scientific_post_journal] • [acf:scientific_post_date]
- Antibiotic stewardship, Epidemiology, Surveillance
- International
- Access, Antibacterial, Approval, Commercial launch